Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Novo Nordisk A/S
Current Parent Company: Novo Holdings A/S
Penalty: $19,000,000
Year: 2015
Date: January 20, 2015
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Novo Nordisk agreed to pay $19 million to settle litigation alleging it violated antitrust law by trying to block the introduction of a generic version of its diabetes treatment Prandin.
Level of Government: federal
Action Type: private litigation
Court: Eastern District of Michigan
Civil or Criminal Case: civil
Case ID: 2:10cv12141
Case Name: American Sales Company, Inc. v. Novo Nordisk A/S et al
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Denmark
Ownership Structure of Current Parent: privately held
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.